447 related articles for article (PubMed ID: 17442306)
21. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
[TBL] [Abstract][Full Text] [Related]
22. Do apoptotic Plasmodium-infected hepatocytes initiate protective immune responses?
Renia L; Maranon C; Hosmalin A; Gruner AC; Silvie O; Snounou G
J Infect Dis; 2006 Jan; 193(1):163-4; author reply 164-5. PubMed ID: 16323145
[No Abstract] [Full Text] [Related]
23. Immunization of monkeys with a 140 kilodalton merozoite surface protein of Plasmodium knowlesi malaria: appearance of alternate forms of this protein.
David PH; Hudson DE; Hadley TJ; Klotz FW; Miller LH
J Immunol; 1985 Jun; 134(6):4146-52. PubMed ID: 3989306
[TBL] [Abstract][Full Text] [Related]
24. [Characterization of a surface antigen of Plasmodium falciparum merozoite with monoclonal antibody].
Jiang CL; Guan WB; Kong XT; Wang XL; Yan YB
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1992; 10(3):184-6. PubMed ID: 1307271
[TBL] [Abstract][Full Text] [Related]
25. Neospora caninum: identification of 19-, 38-, and 40-kDa surface antigens and a 33-kDa dense granule antigen using monoclonal antibodies.
Schares G; Dubremetz JF; Dubey JP; Bärwald A; Loyens A; Conraths FJ
Exp Parasitol; 1999 Jun; 92(2):109-19. PubMed ID: 10366536
[TBL] [Abstract][Full Text] [Related]
26. Plasmodium berghei: characterization of antigens and their role in inducing immunity to infection.
Grothaus GD; Packer BJ; Castilla MM; Muller MT; Kreier JP
J Parasitol; 1984 Dec; 70(6):849-58. PubMed ID: 6396392
[TBL] [Abstract][Full Text] [Related]
27. A liver-stage specific antigen of P. berghei identified by a monoclonal antibody.
Winger L; Suhrbier A; O'Dowd CA; Hodivala KJ; Sinden RE
Bull World Health Organ; 1990; 68 Suppl(Suppl):172-7. PubMed ID: 2094583
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody characterization of Plasmodium falciparum antigens in immune complexes formed when schizonts rupture in the presence of immune serum.
Chulay JD; Lyon JA; Haynes JD; Meierovics AI; Atkinson CT; Aikawa M
J Immunol; 1987 Oct; 139(8):2768-74. PubMed ID: 3309058
[TBL] [Abstract][Full Text] [Related]
29. Plasmodium yoelii: identification of rhoptry proteins using monoclonal antibodies.
Hienne R; Ricard G; Fusaï T; Fujioka H; Pradines B; Aikawa M; Doury JC
Exp Parasitol; 1998 Nov; 90(3):230-5. PubMed ID: 9806867
[TBL] [Abstract][Full Text] [Related]
30. A new approach to generate a safe double-attenuated Plasmodium liver stage vaccine.
Nagel A; Prado M; Heitmann A; Tartz S; Jacobs T; Deschermeier C; Helm S; Stanway R; Heussler V
Int J Parasitol; 2013 May; 43(6):503-14. PubMed ID: 23500072
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
Friesen J; Matuschewski K
Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
[TBL] [Abstract][Full Text] [Related]
32. Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro.
Locher CP; Tam LQ; Chang SP; McBride JS; Siddiqui WA
Exp Parasitol; 1996 Oct; 84(1):74-83. PubMed ID: 8888734
[TBL] [Abstract][Full Text] [Related]
33. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites.
Riggs MW; Stone AL; Yount PA; Langer RC; Arrowood MJ; Bentley DL
J Immunol; 1997 Feb; 158(4):1787-95. PubMed ID: 9029117
[TBL] [Abstract][Full Text] [Related]
34. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
[TBL] [Abstract][Full Text] [Related]
35. Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model.
Yandar N; Pastorin G; Prato M; Bianco A; Patarroyo ME; Lozano JM
Vaccine; 2008 Oct; 26(46):5864-73. PubMed ID: 18771700
[TBL] [Abstract][Full Text] [Related]
36. [Ultrastructural localization of 185 kDa and 82/41 kDa protective antigens in Plasmodium falciparum, FCC1/HN].
Wu LJ; Liu EX; Zhu ZY; Miao WM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1993; 11(1):25-8. PubMed ID: 8403272
[TBL] [Abstract][Full Text] [Related]
37. Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface by antibodies when schizonts mature in the presence of growth inhibitory immune serum.
Lyon JA; Haynes JD; Diggs CL; Chulay JD; Pratt-Rossiter JM
J Immunol; 1986 Mar; 136(6):2252-8. PubMed ID: 3512711
[TBL] [Abstract][Full Text] [Related]
38. A marker epitope of attenuated Plasmodium berghei.
Takagi T; Waki S; Kogure S; Sugioka Y; Suzuki M
Parasitol Res; 1988; 74(5):436-40. PubMed ID: 2457900
[TBL] [Abstract][Full Text] [Related]
39. Toxoplasma gondii: identification and characterization of a cyst molecule.
Zhang YW; Smith JE
Exp Parasitol; 1995 Mar; 80(2):228-33. PubMed ID: 7534723
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine.
Kou X; Zheng W; Du F; Liu F; Wang M; Fan Q; Cui L; Luo E; Cao Y
Parasit Vectors; 2016 Apr; 9():190. PubMed ID: 27038925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
